Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Applied Study on the Impact of Different Early Protein Supplementation Levels on the Prognosis of Neurocritical Patients

NCT07295301 is registered in ClinicalTrials.gov with Wenshan City People's Hospital as lead sponsor.

NCT NCT07295301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07295301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Applied Study on the Impact of Different Early Protein Supplementation Levels on the Prognosis of Neurocritical Patients
Lead sponsor
Wenshan City People's Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2025
Completion date
October 31, 2028
Enrollment
216 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, neurocritical conditions, traumatic brain injury